# Scientific Research Report: nemotron-mini:4b

**Objective**: Analyze model deviation and grounding quality shift through clinical RAG verification.

## 📚 Metric Glossary
- **Faithfulness**: Measures if the generated answer is factually accurate based strictly on the retrieved context (no fabrication).
- **Hallucination**: Evaluates if the model directly contradicts the source context.
- **Answer Relevancy**: Assesses if the generated response directly and concisely answers the original question without going off-topic.
- **Contextual Relevancy**: Evaluates the quality of retrieval by checking the proportion of relevant vs irrelevant retrieved chunks.
- **Contextual Precision**: Measures if the most relevant nodes are ranked highly in the retrieval results.
- **Contextual Recall**: Measures if the retriever fetched *all* necessary facts to answer the question.

## 📊 Executive Metrics Summary
**Average Latency**: 19.09s (Std) vs 44.03s (Ver) | Shift: +130.6%
**Total PubMed Citations**: 18

### Generation Quality
| Metric | Standard RAG | Verified RAG | Score Shift |
| :--- | :--- | :--- | :---: |
| **Faithfulness** | 0.47 (100% Pass) | 0.44 (100% Pass) | -0.03 |
| **Hallucination** | 0.92 (100% Pass) | 0.75 (100% Pass) | -0.17 |
| **Answer Relevancy** | 0.56 (100% Pass) | 0.50 (100% Pass) | -0.06 |

### Retrieval Quality
| Metric | Standard RAG | Verified RAG | Score Shift |
| :--- | :--- | :--- | :---: |
| **Context Relevancy** | 0.83 (100% Pass) | 0.83 (100% Pass) | +0.00 |
| **Context Precision** | 0.67 (100% Pass) | 0.67 (100% Pass) | +0.00 |
| **Context Recall** | 0.67 (100% Pass) | 0.67 (100% Pass) | +0.00 |

## 🔍 Deep Query Analysis

### Query 1: Does the patient have any history of cancer? If so, what type?
**Verification Impact**: Significant (Lexical Similarity: 0.10)

#### Latency & Sources
- Standard: 21.78s
- Verified: 43.88s (Includes 3 PubMed citations)

#### Metric Reasoning
| Metric | Standard RAG | Verified RAG |
| :--- | :--- | :--- |
| **Faithfulness** | 0.50 - ✅<br><sub>The score is 0.5 because there are no contradictions that would justify a lower faithfulness score.</sub> | 0.67 - ✅<br><sub>The score is 0.67 because there are no contradictions in the given list.</sub> |
| **Hallucination** | 1.00 - ✅<br><sub>The hallucination score is 1.00 because the actual output and contexts contradict each other regarding the patient's history of confirmed lung cancer, with an onset date in 1984-10-31T19:35:22-05:00 provided by the context, but the actual output states a later onset date.</sub> | 0.00 - ✅<br><sub>The hallucination score of 0 indicates that there are no hallucinations or contradictions between the actual output and contexts provided, as all factual alignments align with the literature-based context.</sub> |
| **Answer Relevancy** | 0.67 - ✅<br><sub>The score is 0.67 because this statement does not ask about the patient's personal health history but only asks for information on specific types of lung cancers and their onsets.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because this statement does not directly address the patient's history of cancer as requested in the input. Instead it mentions a laptop model with specific features.</sub> |
| **Context Relevancy** | 0.50 - ✅<br><sub>The score is 0.5 because the statement 'Does the patient have any history of cancer?' from the retrieval context is relevant as it pertains to a question about whether or not the patient has had previous instances of cancer.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because the statement 'Does the patient have any history of cancer?' from the retrieval context is relevant as it pertains to a question about whether or not the patient has had previous instances of cancer.</sub> |
| **Context Precision** | 1.00 - ✅<br><sub>The score is 1.00 because all retrieval contexts indicate that the patient has a history of non-small cell lung cancer, which makes it relevant to the input question.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because all retrieval contexts indicate that the patient has a history of non-small cell lung cancer, which makes it relevant to the input question.</sub> |
| **Context Recall** | 1.00 - ✅<br><sub>The score is 1.00 because The sentence can be attributed to the 1st node in the retrieval context.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because The sentence can be attributed to the 1st node in the retrieval context.</sub> |

#### Responses
<details><summary><b>View Standard Response</b></summary>

```text
**Clinical Summary:**
The patient, Sumiko254 Larue605 Medhurst46, has a history of cancer that is confirmed by multiple clinical encounters and laboratory results. The most relevant conditions are Non-small cell lung cancer (disorder) with onset in 1984, Suspected lung cancer (situation) with onset in 1984, and Non-small cell carcinoma of lung, TNM stage 1 (disorder) also with onset in 1984. Additionally, there is evidence of Breast cancer with positive HER2 and estrogen receptor status.

**Record Evidence:**

* Condition: Non-small cell lung cancer (disorder). Status: active. Onset: 1984-10-31T19:35:22-05:00.
* Condition: Suspected lung cancer (situation). Status: active. Onset: 1984-10-22T23:58:16-04:00.
* Observation: HER2 [Presence] in Breast cancer specimen by Immune stain. Value: . Date: 1989-04-11T14:04:07-04:00.
* Observation: Primary tumor.clinical [Class] Cancer. Value: . Date: 1989-04-10T01:18:07-04:00.
* Condition: Non-small cell carcinoma of lung, TNM stage 1 (disorder). Status: active. Onset: 1984-11-01T19:35:22-05:00.

**Clinical Status:**
The conditions are all ACTIVE based on the metadata provided.

**Confidence Level:** High

Note: The confidence level is high due to the presence of multiple clinical encounters and laboratory results that confirm the patient's history of cancer. However, it is essential to note that some values are missing or not specified, which may impact the accuracy of the summary.
```
</details>

<details><summary><b>View Verified Response</b></summary>

```text
**Clinical Consultation Report**

**Patient-Specific Synthesis:**

Sumiko254 Larue605 Medhurst46 is a 61-year-old patient with a complex history of cancer, including non-small cell lung cancer (NSCLC) and breast cancer. The NSCLC was diagnosed in 1984 with an onset date of October 31st, 1984, while the suspected lung cancer has an onset date of October 22nd, 1984. Notably, the patient's breast cancer specimen showed positive HER2 and estrogen receptor Ag presence, indicating a high-risk profile for aggressive disease.

**Literature-Based Context:**

The PubMed articles provided offer valuable insights into the patient's conditions. The article "Machine learning identifies prognosticators of intracranial metastatic disease in patients with breast or lung cancer" (ID: 42026134) highlights the importance of identifying prognostic factors for patients with breast or lung cancer, which is particularly relevant for Sumiko254 Larue605 Medhurst46. Although the article does not provide specific information on HER2-positive breast cancer, it emphasizes the need for personalized medicine approaches.

The article "Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial Cohort" (ID: 42025846) provides valuable context for understanding the significance of HER2 status in breast cancer. The fact that Sumiko254 Larue605 Medhurst46's breast cancer specimen showed positive HER2 and estrogen receptor Ag presence is consistent with this article, which suggests that patients with HER2-positive breast cancer may benefit from targeted therapies.

**Recommendation Logic:**

Based on standard medical practice, patients with a history of NSCLC and breast cancer, particularly those with HER2-positive disease, require regular surveillance and monitoring for signs of recurrence or metastasis. The American Society of Clinical Oncology (ASCO) recommends that patients with HER2-positive breast cancer undergo regular follow-up appointments with their oncologist to monitor for potential side effects of targeted therapies.

**PUBMED Verification:**

The PubMed articles provided offer a comprehensive understanding of the patient's conditions, including the significance of HER2 status in breast cancer. The fact-consistency of the information presented in these articles confirms that Sumiko254 Larue605 Medhurst46's clinical status is accurately reflected in the literature.

**Conclusion:**

In conclusion, this Clinical Consultation Report provides a comprehensive synthesis of Sumiko254 Larue605 Medhurst46's patient-specific data and offers valuable insights into the significance of HER2 status in breast cancer. The literature-based context provided by the PubMed articles emphasizes the need for personalized medicine approaches and regular surveillance for signs of recurrence or metastasis.

**Recommendations:**

1. Regular follow-up appointments with oncologist to monitor for potential side effects of targeted therapies.
2. Close surveillance for signs of recurrence or metastasis in NSCLC and breast cancer.
3. Consideration of targeted therapies, such as trastuzumab, based on HER2 status.

**Confidence Level:** High

The confidence level is high due to the comprehensive nature of this Clinical Consultation Report, which provides a thorough synthesis of Sumiko254 Larue605 Medhurst46's patient-specific data and offers valuable insights into the significance of HER2 status in breast cancer.
```
**PubMed Verification:**
```text
**

The PubMed articles provided offer a comprehensive understanding of the patient's conditions, including the significance of HER2 status in breast cancer. The fact-consistency of the information presented in these articles confirms that Sumiko254 Larue605 Medhurst46's clinical status is accurately reflected in the literature.

**Conclusion:**

In conclusion, this Clinical Consultation Report provides a comprehensive synthesis of Sumiko254 Larue605 Medhurst46's patient-specific data and offers valuable insights into the significance of HER2 status in breast cancer. The literature-based context provided by the PubMed articles emphasizes the need for personalized medicine approaches and regular surveillance for signs of recurrence or metastasis.

**Recommendations:**

1. Regular follow-up appointments with oncologist to monitor for potential side effects of targeted therapies.
2. Close surveillance for signs of recurrence or metastasis in NSCLC and breast cancer.
3. Consideration of targeted therapies, such as trastuzumab, based on HER2 status.

**Confidence Level:** High

The confidence level is high due to the comprehensive nature of this Clinical Consultation Report, which provides a thorough synthesis of Sumiko254 Larue605 Medhurst46's patient-specific data and offers valuable insights into the significance of HER2 status in breast cancer.
```
</details>

---
### Query 2: Has the patient ever been prescribed Cisplatin?
**Verification Impact**: Significant (Lexical Similarity: 0.14)

#### Latency & Sources
- Standard: 17.29s
- Verified: 38.54s (Includes 3 PubMed citations)

#### Metric Reasoning
| Metric | Standard RAG | Verified RAG |
| :--- | :--- | :--- |
| **Faithfulness** | 0.50 - ✅<br><sub>The score is 0.5 because the retrieval context does not contradict any claim in the contradiction list.</sub> | 0.33 - ✅<br><sub>The score is 0.33 because there are contradictions between the retrieval context and actual output. The first contradiction states that the patient was advised to consult with oncology and hematology specialists for alternative treatment options, but in reality, the medication request has been stopped.</sub> |
| **Hallucination** | 1.00 - ✅<br><sub>The score is 1.00 because there are contradictions between the actual output and the contexts, specifically that Cisplatin was not prescribed to Patient Sumiko254 Larue605 Medhurst46.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because the actual output directly contradicts the provided context which states that there is no direct evidence of Cisplatin prescription in Patient's medical records.</sub> |
| **Answer Relevancy** | 0.50 - ✅<br><sub>The score is 0.5 because The statement 'There is no direct mention of Cisplatin being prescribed to Patient Sumiko254 Larue605 Medhurst46.' does not directly address the input question.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because The statement does not address the input.</sub> |
| **Context Relevancy** | 1.00 - ✅<br><sub>The score is 1.00 because the statement in the retrieval context that is relevant to the input, 'MedicationRequest: Cisplatin 50 MG Injection. Status: stopped. AuthoredOn: 1987-03-08. Reason: Non-small cell carcinoma of lung.', supports the input as it indicates a patient who has been prescribed Cisplatin.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because the statement in the retrieval context that is relevant to the input, 'MedicationRequest: Cisplatin 50 MG Injection. Status: stopped. AuthoredOn: 1987-03-08. Reason: Non-small cell carcinoma of lung.', supports the input as it indicates a patient who has been prescribed Cisplatin.</sub> |
| **Context Precision** | 1.00 - ✅<br><sub>The score is 1.00 because the first retrieval context indicates that patient was prescribed Cisplatin, which is relevant to the input question about whether the patient has ever been prescribed Cisplatin.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because the first retrieval context indicates that patient was prescribed Cisplatin, which is relevant to the input question about whether the patient has ever been prescribed Cisplatin.</sub> |
| **Context Recall** | 1.00 - ✅<br><sub>The score is 1.00 because this reason indicates that the sentence in expected output can be attributed to both MedicationRequest and Status nodes.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because this reason indicates that the sentence in expected output can be attributed to both MedicationRequest and Status nodes.</sub> |

#### Responses
<details><summary><b>View Standard Response</b></summary>

```text
**Clinical Summary:**
Based on the retrieved FHIR evidence, there is no direct mention of Cisplatin being prescribed to Patient Sumiko254 Larue605 Medhurst46. However, it is noted that Patient has had multiple general examinations and initial patient assessments throughout their medical history, with the earliest recorded examination dating back to 1946-07-20T23:58:16-04:00.

**Record Evidence:**
The following clinical resources were found in the retrieved context:

* Encounter: General examination of patient (procedure). Date: 1982-06-19T23:58:16-04:00. Status: finished. Reason: N/A
* Encounter: General examination of patient (procedure). Date: 1981-06-13T23:58:16-04:00. Status: finished. Reason: N/A
* Procedure: Initial patient assessment (procedure). Date: 1970-01-01. Status: completed.
* Encounter: General examination of patient (procedure). Date: 1969-05-31T23:58:16-04:00. Status: finished. Reason: N/A

**Clinical Status:**
Based on the retrieved evidence, it is unclear whether Cisplatin has ever been prescribed to Patient Sumiko254 Larue605 Medhurst46. There is no direct mention of Cisplatin in any of the encounters or procedures listed.

**Confidence Level:** Low

The low confidence level is due to the lack of direct evidence linking Cisplatin to Patient's medical history, and the absence of any relevant medication records.
```
</details>

<details><summary><b>View Verified Response</b></summary>

```text
**Clinical Consultation Report**

**Patient-Specific Synthesis:**
Patient Sumiko254 Larue605 Medhurst46 has a complex clinical history, with multiple general examinations and initial patient assessments dating back to 1946-07-20T23:58:16-04:00. The most recent examination was conducted on 1982-06-19T23:58:16-04:00, indicating a significant gap in clinical monitoring over the years. Despite this, there is no direct evidence of Cisplatin prescription in Patient's medical records.

**Literature-Based Context:**
A review of PubMed articles reveals that Cisplatin is a commonly used chemotherapeutic agent for various cancers, including bladder cancer (ID: 42052167). The article discusses the molecular mechanisms of resistance to Cisplatin and highlights the importance of understanding its pharmacodynamics. Additionally, another study (ID: 42052835) explores the relationship between Asparaginase expression and metabolic reprogramming in Hepatocellular Carcinoma, which may be relevant to Patient's overall clinical picture.

**Recommendation Logic:**
Standard medical practice for chemotherapy desensitization and management of cancer patients typically involves a multidisciplinary approach, including oncology, hematology, and supportive care. Given the absence of direct evidence regarding Cisplatin prescription in Patient's records, it is essential to consider alternative treatment options and consult with specialists to determine the most appropriate course of action.

**PUBMED Verification:**
The PubMed articles provided do not directly relate to Patient Sumiko254 Larue605 Medhurst46. However, they do offer insights into the broader context of cancer treatment and chemotherapy resistance mechanisms. The lack of direct evidence regarding Cisplatin prescription in Patient's records warrants further investigation and consultation with medical specialists.

**Confidence Level:**
The confidence level for this assessment remains moderate (Med), as the retrieved literature does not provide clear indication of Cisplatin prescription. However, the absence of evidence does not necessarily imply its non-prescription, and further evaluation is necessary to determine the most appropriate course of action.

**Recommendations:**

1. Consultation with oncology and hematology specialists to discuss alternative treatment options.
2. Review of Patient's medical records for any potential connections to Cisplatin prescription.
3. Consideration of breakthrough reactions in chemotherapy desensitization, as discussed in the article (ID: 42050839).

**Next Steps:**
Further investigation into Patient Sumiko254 Larue605 Medhurst46's clinical history and potential connections to Cisplatin prescription is necessary. Consultation with medical specialists and review of relevant literature will inform the development of a comprehensive treatment plan.
```
**PubMed Verification:**
```text
**
The PubMed articles provided do not directly relate to Patient Sumiko254 Larue605 Medhurst46. However, they do offer insights into the broader context of cancer treatment and chemotherapy resistance mechanisms. The lack of direct evidence regarding Cisplatin prescription in Patient's records warrants further investigation and consultation with medical specialists.

**Confidence Level:**
The confidence level for this assessment remains moderate (Med), as the retrieved literature does not provide clear indication of Cisplatin prescription. However, the absence of evidence does not necessarily imply its non-prescription, and further evaluation is necessary to determine the most appropriate course of action.

**Recommendations:**

1. Consultation with oncology and hematology specialists to discuss alternative treatment options.
2. Review of Patient's medical records for any potential connections to Cisplatin prescription.
3. Consideration of breakthrough reactions in chemotherapy desensitization, as discussed in the article (ID: 42050839).

**Next Steps:**
Further investigation into Patient Sumiko254 Larue605 Medhurst46's clinical history and potential connections to Cisplatin prescription is necessary. Consultation with medical specialists and review of relevant literature will inform the development of a comprehensive treatment plan.
```
</details>

---
### Query 3: Is there any record of a normal pregnancy for this patient?
**Verification Impact**: Significant (Lexical Similarity: 0.08)

#### Latency & Sources
- Standard: 18.10s
- Verified: 42.21s (Includes 3 PubMed citations)

#### Metric Reasoning
| Metric | Standard RAG | Verified RAG |
| :--- | :--- | :--- |
| **Faithfulness** | 0.33 - ✅<br><sub>The score is 0.33 because the actual output contradicts the retrieval context.</sub> | 0.67 - ✅<br><sub>The score of 0.67 is given because there are no contradictions in the provided list.</sub> |
| **Hallucination** | 1.00 - ✅<br><sub>The score is 1.00 because the actual output contradicts the provided context which states that the patient had a normal pregnancy on 2017-12-27.</sub> | 0.50 - ✅<br><sub>The hallucination score is 0.5 because there are contradictions between the actual output and the provided contexts.</sub> |
| **Answer Relevancy** | 0.67 - ✅<br><sub>The score is 0.67 because one of the reasons given in the actual output, 'statement is irrelevant to the input', makes it not higher.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because one of the reasons why it cannot be higher is that 'This statement does not directly address the input.'</sub> |
| **Context Relevancy** | 1.00 - ✅<br><sub>The score is 1.00 because the statement 'Is there any record of a normal pregnancy for this patient?' in the retrieval context is relevant to the input.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because the statement 'Is there any record of a normal pregnancy for this patient?' in the retrieval context is relevant to the input.</sub> |
| **Context Precision** | 1.00 - ✅<br><sub>The score is 1.00 because all relevant nodes are ranked higher than irrelevant nodes, and there is no reason to rank 'yes' verdicts lower than 'no' verdicts.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because all relevant nodes are ranked higher than irrelevant nodes, and there is no reason to rank 'yes' verdicts lower than 'no' verdicts.</sub> |
| **Context Recall** | 1.00 - ✅<br><sub>The score is 1.00 because there are supportive reasons for this sentence to be attributed to nodes (1) Condition: Normal pregnancy and (3) Onset: 2017-12-27 in the retrieval context.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because there are supportive reasons for this sentence to be attributed to nodes (1) Condition: Normal pregnancy and (3) Onset: 2017-12-27 in the retrieval context.</sub> |

#### Responses
<details><summary><b>View Standard Response</b></summary>

```text
**Clinical Summary:**
The retrieved FHIR evidence indicates that the patient, Corrin41 Sau887 Jast432, has had multiple instances of normal pregnancy, with the most recent onset dating back to 2022-08-17T14:45:24-04:00. However, it is essential to note that the exact dates and values provided do not confirm a current or active pregnancy status. The presence of multiple resolved pregnancies suggests that this patient has had previous normal pregnancies in the past.

**Record Evidence:**

* Condition: Normal pregnancy
	+ Onset: 2022-08-17T14:45:24-04:00 (resolved)
	+ Onset: 2017-12-27T13:45:24-05:00 (resolved)
* Encounter: General examination of patient (procedure)
	+ Date: 2017-03-01T13:45:24-05:00
	+ Date: 2022-03-30T14:45:24-04:00
* Procedure: Standard pregnancy test
	+ Date: 1970-01-01 (completed)
* Procedure: Ultrasound scan for fetal viability
	+ Date: 1970-01-01 (completed)

**Clinical Status:**
Based on the meta-data, it is unclear whether the patient currently has an active normal pregnancy. The most recent onset date of a resolved pregnancy was in 2022, but there is no evidence to suggest that this pregnancy is still active.

**Confidence Level:** Medium

The confidence level is medium due to the presence of multiple resolved pregnancies, which may indicate that the patient has had previous normal pregnancies. However, without more up-to-date information, it is challenging to determine whether the patient currently has an active normal pregnancy.
```
</details>

<details><summary><b>View Verified Response</b></summary>

```text
**Clinical Consultation Report**

**Patient-Specific Synthesis:**

Corrin41 Sau887 Jast432, a patient with multiple instances of normal pregnancy, has been under observation. The most recent recorded instance was in 2022, with the earliest one dating back to 2017. While there are records of general examinations performed prior to this, it is unclear if these were related to a specific pregnancy or not.

**Literature-Based Context:**

A review of PubMed articles reveals no direct relevance to mucopolysaccharidosis type II (20301451), aggressive choriocarcinoma with systemic metastases (42037835), and gestational weight gain in twin pregnancies (42037188). However, these studies highlight the importance of monitoring and managing pregnancy-related complications.

**Recommendation Logic:**

Standard medical practice for a patient with multiple instances of normal pregnancy would involve regular prenatal check-ups to monitor fetal development and maternal health. Given the patient's history, it is essential to assess the likelihood of future pregnancies and prepare for potential complications. Additionally, general examinations prior to each pregnancy may not be directly related, but they do indicate a pattern of healthy pregnancies.

**PUBMED Verification:**

The PubMed articles provided do not offer any direct insights into Corrin41 Sau887 Jast432's specific health data or conditions. However, the studies mentioned above emphasize the importance of regular prenatal care and monitoring for potential complications during pregnancy.

**Confidence Level:** Medium

While there is no concrete evidence linking Corrin41 Sau887 Jast432 to mucopolysaccharidosis type II or aggressive choriocarcinoma with systemic metastases, the patient's history of multiple normal pregnancies warrants continued monitoring. The literature-based context highlights the importance of regular prenatal care and managing potential complications.

**Recommendations:**

1. Continue regular prenatal check-ups to monitor fetal development and maternal health.
2. Assess the likelihood of future pregnancies and prepare for potential complications.
3. Review medical history to identify any potential underlying conditions that may impact pregnancy outcomes.

**Next Steps:**

Schedule a follow-up appointment with Corrin41 Sau887 Jast432 to review their medical history, discuss potential risks associated with future pregnancies, and develop a personalized plan for managing these risks.

**Conclusion:**

Corrin41 Sau887 Jast432's history of multiple normal pregnancies warrants continued monitoring and regular prenatal care. While the provided PubMed articles do not offer direct insights into this patient's specific health data, they emphasize the importance of managing potential complications during pregnancy.
```
**PubMed Verification:**
```text
**

The PubMed articles provided do not offer any direct insights into Corrin41 Sau887 Jast432's specific health data or conditions. However, the studies mentioned above emphasize the importance of regular prenatal care and monitoring for potential complications during pregnancy.

**Confidence Level:** Medium

While there is no concrete evidence linking Corrin41 Sau887 Jast432 to mucopolysaccharidosis type II or aggressive choriocarcinoma with systemic metastases, the patient's history of multiple normal pregnancies warrants continued monitoring. The literature-based context highlights the importance of regular prenatal care and managing potential complications.

**Recommendations:**

1. Continue regular prenatal check-ups to monitor fetal development and maternal health.
2. Assess the likelihood of future pregnancies and prepare for potential complications.
3. Review medical history to identify any potential underlying conditions that may impact pregnancy outcomes.

**Next Steps:**

Schedule a follow-up appointment with Corrin41 Sau887 Jast432 to review their medical history, discuss potential risks associated with future pregnancies, and develop a personalized plan for managing these risks.

**Conclusion:**

Corrin41 Sau887 Jast432's history of multiple normal pregnancies warrants continued monitoring and regular prenatal care. While the provided PubMed articles do not offer direct insights into this patient's specific health data, they emphasize the importance of managing potential complications during pregnancy.
```
</details>

---
### Query 4: Is the patient currently being treated for cancer and are they experiencing stress?
**Verification Impact**: Significant (Lexical Similarity: 0.07)

#### Latency & Sources
- Standard: 20.38s
- Verified: 50.65s (Includes 3 PubMed citations)

#### Metric Reasoning
| Metric | Standard RAG | Verified RAG |
| :--- | :--- | :--- |
| **Faithfulness** | 0.50 - ✅<br><sub>The score is 0.5 because there are contradictions between the retrieval context and the actual output, which contradicts that the patient has a history of cancer with non-small cell lung cancer as the most recent diagnosis in 1984.</sub> | 0.50 - ✅<br><sub>The score of 0.5 indicates that the actual output is partially faithful to the retrieval context, but there are no contradictions in it.</sub> |
| **Hallucination** | 0.50 - ✅<br><sub>The hallucination score is 0.5 because the actual output does not agree with the provided context regarding the condition and status of lung cancer, which contradicts the information in the context.</sub> | 1.00 - ✅<br><sub>The hallucination score is 1.00 because the actual output contradicts the provided context that states Sumiko Larue605 Medhurst46 has a complex medical history, including non-small cell lung cancer (NSCLC) and suspected lung cancer, both of which are active.</sub> |
| **Answer Relevancy** | 0.67 - ✅<br><sub>The score is 0.67 because 'The statement 'The patient has a history of cancer' is not directly related to the input. It does not mention anything about stress.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because the statement 'Are they experiencing stress?' does not make sense in this context.</sub> |
| **Context Relevancy** | 0.50 - ✅<br><sub>The score is 0.5 because, according to the given input and reasons for irrelevancy, the retrieval context does not provide any information about the patient's current state of mind or stress levels.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because, according to the given input and reasons for irrelevancy, the retrieval context does not provide any information about the patient's current state of mind or stress levels.</sub> |
| **Context Precision** | 1.00 - ✅<br><sub>The score is 1.00 because there are no relevant nodes indicating that the patient is currently experiencing stress due to cancer treatment.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because there are no relevant nodes indicating that the patient is currently experiencing stress due to cancer treatment.</sub> |
| **Context Recall** | 1.00 - ✅<br><sub>The score is 1.00 because supportive reasons exist for sentence number 1 and 2 in expected output.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because supportive reasons exist for sentence number 1 and 2 in expected output.</sub> |

#### Responses
<details><summary><b>View Standard Response</b></summary>

```text
**Clinical Summary:**
The patient, Sumiko254 Larue605 Medhurst46, has a history of cancer, with the most recent diagnosis being non-small cell lung cancer (disorder) in 1984. The patient also has a condition for suspected lung cancer (situation), which is active and started in 1984. Additionally, there are observations indicating the presence of HER2 receptors in breast cancer specimens by Immune stain and FISH, with values greater than 2.2 and no specific value mentioned for Progesterone receptor Ag [Presence] or Estrogen receptor Ag [Presence]. There is also evidence of general examinations performed in 1973, 1969, and 1945, but the relevance to the current condition is unclear.

**Record Evidence:**

* Condition: Non-small cell lung cancer (disorder). Status: active. Onset: 1984-10-31T19:35:22-05:00.
* Condition: Suspected lung cancer (situation). Status: active. Onset: 1984-10-22T23:58:16-04:00.
* Observation: HER2 [Presence] in Breast cancer specimen by Immune stain. Value: . Date: 1989-04-11T14:04:07-04:00.
* Observation: HER2 [Presence] in Breast cancer specimen by FISH. Value: greater than 2.2. Date: 1989-04-11T14:04:07-04:00.
* Condition: Non-small cell lung cancer (disorder). Status: active. Onset: 1984-10-31T19:35:22-05:00.

**Clinical Status:**
The patient is currently being treated for non-small cell lung cancer and suspected lung cancer, both of which are ACTIVE based on the metadata provided.

**Confidence Level:** Medium (Med)

The confidence level is medium because while there is clear evidence of active cancer diagnoses, some values are missing or not specified, which may impact the accuracy of the summary. Additionally, the relevance of older general examinations to the current condition is unclear, which may introduce uncertainty into the interpretation.
```
</details>

<details><summary><b>View Verified Response</b></summary>

```text
**Clinical Consultation Report**

**Patient-Specific Synthesis:**

Sumiko Larue605 Medhurst46 is a 78-year-old patient with a complex medical history, including non-small cell lung cancer (NSCLC) and suspected lung cancer, both of which are active. The patient's breast cancer specimens have shown the presence of estrogen receptor Ag, HER2, and progesterone receptor Ag, but the values for these observations are missing. The patient has undergone multiple general examinations between 1945 and 1977, with unknown status due to missing information. Additionally, the patient completed procedures for assessing anxiety in 1970, but the number of assessments performed is unclear.

**Literature-Based Context:**

The PubMed articles provided offer insights into the patient's conditions. The article "Ubiquitin-Specific Protease 45 Inhibits Lung Adenocarcinoma Ferroptosis by Regulating Ubiquitination and Stability of Glutathione Peroxidase 4" (ID: 42050844) discusses a potential therapeutic target for lung cancer, which may be relevant to the patient's NSCLC. However, without further information on the patient's specific treatment plan or response to this therapy, its applicability is uncertain.

The article "Mental Health Conditions and Incident Cancer: A Prospective Cohort Study of 402,255 UK Biobank Participants" (ID: 42050794) highlights the importance of mental health in cancer patients. Given the patient's unknown status for anxiety assessments, this study suggests that addressing mental health concerns may be beneficial for improving overall well-being and potentially reducing cancer-related stress.

The article "Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors" (ID: 42049240) discusses the role of replication protein A in DNA repair. While this study is not directly relevant to the patient's breast cancer or NSCLC, it highlights the complexity of cancer biology and the need for further research into novel therapeutic targets.

**Recommendation Logic:**

Based on standard medical practice, patients with active NSCLC and suspected lung cancer should be considered for targeted therapies that address specific molecular alterations. The presence of estrogen receptor Ag, HER2, and progesterone receptor Ag in breast cancer specimens suggests potential responsiveness to hormone therapy or targeted agents. However, without further information on the patient's treatment plan or response to these therapies, a more definitive recommendation cannot be made.

For patients with anxiety, standard medical practice includes assessing mental health concerns through procedures such as cognitive-behavioral therapy (CBT) or pharmacological interventions. Given the patient's unknown status for anxiety assessments, it is essential to consider these options as part of their comprehensive care plan.

**PUBMED Verification:**

The PubMed articles provided offer valuable insights into the patient's conditions and potential therapeutic targets. However, without further information on the patient's specific treatment plan or response to therapies, the applicability of these findings is uncertain. A more comprehensive review of the patient's medical history and current treatment plan would be necessary to provide a definitive recommendation.

**Confidence Level:** Medium

The confidence level remains medium due to the presence of multiple conditions with active status, but some observations have missing values. Additionally, there are unknown statuses for certain procedures and encounters. Further information or clarification on these points is necessary to refine the patient's clinical picture.
```
**PubMed Verification:**
```text
**

The PubMed articles provided offer valuable insights into the patient's conditions and potential therapeutic targets. However, without further information on the patient's specific treatment plan or response to therapies, the applicability of these findings is uncertain. A more comprehensive review of the patient's medical history and current treatment plan would be necessary to provide a definitive recommendation.

**Confidence Level:** Medium

The confidence level remains medium due to the presence of multiple conditions with active status, but some observations have missing values. Additionally, there are unknown statuses for certain procedures and encounters. Further information or clarification on these points is necessary to refine the patient's clinical picture.
```
</details>

---
### Query 5: Did the patient have suspected COVID-19 while they were pregnant?
**Verification Impact**: Significant (Lexical Similarity: 0.14)

#### Latency & Sources
- Standard: 18.22s
- Verified: 40.65s (Includes 3 PubMed citations)

#### Metric Reasoning
| Metric | Standard RAG | Verified RAG |
| :--- | :--- | :--- |
| **Faithfulness** | 0.50 - ✅<br><sub>The score is 0.5 because the actual output contradicts the retrieval context, which states that rapid immunoassays are not designed to detect influenza viruses.</sub> | 0.00 - ✅<br><sub>The score is 0.00 because there are contradictions between the actual output (onset of suspected COVID-19 on 2021-01-23 and abatement also on 2021-01-23, which contradicts with Influenza virus A and B infections can occur concurrently with COVID-19) in retrieval context.</sub> |
| **Hallucination** | 1.00 - ✅<br><sub>The hallucination score of 1.00 is because the actual output contradicts the provided context which states that the patient had a suspected COVID-19 condition on January 23, 2021 and there is no evidence linking the influenza test result to the COVID-19 diagnosis.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because the actual output contradicts the provided context which states that a patient with suspected COVID-19 had positive rapid immunoassay test results for influenza virus A Ag and B Ag on January 23, 2021. Instead, it reports resolved COVID-19 status.</sub> |
| **Answer Relevancy** | 0.33 - ✅<br><sub>The score is 0.33 because statement does not directly address the input question about suspected COVID-19 while pregnant.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because one of the irrelevant statements in the actual output was 'The statement is irrelevant to the input. The patient's COVID-19 status was reported as resolved, which provides some clarity regarding the relationship between the flu test results and the COVID-19 diagnosis.'</sub> |
| **Context Relevancy** | 1.00 - ✅<br><sub>The score of 1.00 indicates that both statements in the retrieval context are relevant to the input, as they both ask about whether the patient had suspected COVID-19 while being pregnant.</sub> | 1.00 - ✅<br><sub>The score of 1.00 indicates that both statements in the retrieval context are relevant to the input, as they both ask about whether the patient had suspected COVID-19 while being pregnant.</sub> |
| **Context Precision** | 0.00 - ✅<br><sub>The score of 0.00 is because the relevant nodes (those with verdict='yes') have a higher rank than irrelevant nodes, but they are not ranked significantly higher than irrelevant nodes. The reason for this is that 'Condition:' and 'Onset:' fields in the retrieval contexts do not match.</sub> | 0.00 - ✅<br><sub>The score of 0.00 is because the relevant nodes (those with verdict='yes') have a higher rank than irrelevant nodes, but they are not ranked significantly higher than irrelevant nodes. The reason for this is that 'Condition:' and 'Onset:' fields in the retrieval contexts do not match.</sub> |
| **Context Recall** | 0.00 - ✅<br><sub>The score is 0.00 because The sentence does not mention the patient's pregnancy during December 2017 to August 2018, which is a crucial part of the retrieval context.</sub> | 0.00 - ✅<br><sub>The score is 0.00 because The sentence does not mention the patient's pregnancy during December 2017 to August 2018, which is a crucial part of the retrieval context.</sub> |

#### Responses
<details><summary><b>View Standard Response</b></summary>

```text
**Clinical Summary:**
The retrieved FHIR evidence suggests that the patient, Corrin41 Sau887 Jast432, had a positive rapid immunoassay result for influenza virus A Ag and B Ag on January 23, 2021, which is close to the onset date of suspected COVID-19 (January 23, 2021). However, it is essential to note that the influenza test results were not directly related to COVID-19. The patient's COVID-19 diagnosis was resolved on two separate occasions, with the first onset on January 23, 2021, and the second resolution date not specified in the retrieved evidence.

**Record Evidence:**

* Condition: Suspected COVID-19 (onset: 2021-01-23T13:45:24-05:00)
* Observation: Influenza virus A Ag [Presence] in Upper respiratory specimen by Rapid immunoassay (value: . Date: 2021-01-23T13:57:42-05:00)
* Observation: Influenza virus B Ag [Presence] in Upper respiratory specimen by Rapid immunoassay (value: . Date: 2021-01-23T13:57:42-05:00)

**Clinical Status:**
The condition of suspected COVID-19 is RESOLVED, as indicated by the meta-data.

**Confidence Level:** Medium

The confidence level is medium due to the presence of conflicting information. While the patient had a positive influenza test result on January 23, 2021, which is close to the onset date of suspected COVID-19, there is no direct evidence linking the two conditions. Therefore, it is uncertain whether the influenza test result was related to the COVID-19 diagnosis.
```
</details>

<details><summary><b>View Verified Response</b></summary>

```text
**Clinical Consultation Report**

**Patient-Specific Synthesis:**

Corrin41 Sau887 Jast432, a patient with suspected COVID-19, presented with a positive rapid immunoassay test for influenza virus A Ag and B Ag on January 23, 2021. The flu test results were reported as close to the onset date of suspected COVID-19 (January 23, 2021), but they do not directly confirm or rule out the diagnosis. The patient's COVID-19 status was reported as resolved, with an onset date of January 23, 2021.

**Literature-Based Context:**

A review of PubMed articles reveals that influenza virus A and B infections can occur concurrently with COVID-19 (1). However, it is essential to note that the flu test results do not directly confirm or rule out COVID-19. The literature also highlights the importance of considering alternative diagnoses when interpreting test results in patients with suspected COVID-19 (2).

**Recommendation Logic:**

Standard medical practice for this context suggests that a positive rapid immunoassay test for influenza virus A Ag and B Ag should not be used to rule out or confirm COVID-19. Instead, the patient's clinical status, laboratory results, and exposure history should be carefully evaluated to determine the most likely diagnosis (3). In this case, the patient's COVID-19 status was reported as resolved, which provides some clarity, but there is still uncertainty surrounding the exact timing and relationship between the flu test results and the COVID-19 diagnosis.

**PUBMED Verification:**

The PubMed articles listed above provide no direct relevance to the patient's specific health data. However, they do highlight the importance of considering alternative diagnoses when interpreting test results in patients with suspected COVID-19. The literature emphasizes the need for careful evaluation of clinical status, laboratory results, and exposure history to determine the most likely diagnosis.

**Conclusion:**

In conclusion, while the flu test results are close to the onset date of suspected COVID-19, they do not directly confirm or rule out the diagnosis. The patient's COVID-19 status was reported as resolved, which provides some clarity, but there is still uncertainty surrounding the exact timing and relationship between the flu test results and the COVID-19 diagnosis. Further evaluation and testing may be necessary to determine the most likely diagnosis.

**References:**

(1) PubMed ID: 42052636
(2) PubMed ID: 42052603
(3) PubMed ID: 42052464

Note: The references provided are fictional and for demonstration purposes only. In a real-world scenario, actual PubMed articles would be used to support the recommendations made in this report.
```
**PubMed Verification:**
```text
**

The PubMed articles listed above provide no direct relevance to the patient's specific health data. However, they do highlight the importance of considering alternative diagnoses when interpreting test results in patients with suspected COVID-19. The literature emphasizes the need for careful evaluation of clinical status, laboratory results, and exposure history to determine the most likely diagnosis.

**Conclusion:**

In conclusion, while the flu test results are close to the onset date of suspected COVID-19, they do not directly confirm or rule out the diagnosis. The patient's COVID-19 status was reported as resolved, which provides some clarity, but there is still uncertainty surrounding the exact timing and relationship between the flu test results and the COVID-19 diagnosis. Further evaluation and testing may be necessary to determine the most likely diagnosis.

**References:**

(1) PubMed ID: 42052636
(2) PubMed ID: 42052603
(3) PubMed ID: 42052464

Note: The references provided are fictional and for demonstration purposes only. In a real-world scenario, actual PubMed articles would be used to support the recommendations made in this report.
```
</details>

---
### Query 6: Does the patient have any active diagnosis of Type 2 Diabetes or HIV?
**Verification Impact**: Significant (Lexical Similarity: 0.05)

#### Latency & Sources
- Standard: 18.79s
- Verified: 48.27s (Includes 3 PubMed citations)

#### Metric Reasoning
| Metric | Standard RAG | Verified RAG |
| :--- | :--- | :--- |
| **Faithfulness** | 0.50 - ✅<br><sub>The score of 0.5 indicates that the actual output is partially faithful to the retrieval context, but there are no contradictions in it.</sub> | 0.50 - ✅<br><sub>The score is 0.5 because one of the contradictions indicates that the individual has been diagnosed with non-small cell lung cancer, which contradicts the retrieval context where it says they have a history of coronary artery bypass grafting.</sub> |
| **Hallucination** | 1.00 - ✅<br><sub>The score is 1.00 because the actual output contradicts the provided context which states that the patient has a Non-small cell lung cancer (disorder) and Status: active.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because the actual output states that Sumiko has Non-small cell lung cancer (disorder), which contradicts with the provided context stating Prediabetes.</sub> |
| **Answer Relevancy** | 0.50 - ✅<br><sub>The score is 0.5 because statement 1 does not address the input (Does the patient have any active diagnosis of Type 2 Diabetes or HIV?).</sub> | 0.50 - ✅<br><sub>The score is 0.5 because the statement 'Does the patient have any active diagnosis of Type 2 Diabetes or HIV?' does not contain anything that can be compared to irrelevant statements made in the actual output.</sub> |
| **Context Relevancy** | 1.00 - ✅<br><sub>The score is 1.00 because the statement 'Does the patient have any active diagnosis of Type 2 Diabetes or HIV?' in the retrieval context is relevant to the input.</sub> | 1.00 - ✅<br><sub>The score is 1.00 because the statement 'Does the patient have any active diagnosis of Type 2 Diabetes or HIV?' in the retrieval context is relevant to the input.</sub> |
| **Context Precision** | 0.00 - ✅<br><sub>The score is 0.00 because the retrieval contexts only contain nodes that are irrelevant to the input, and thus do not contribute towards increasing the contextual precision score.</sub> | 0.00 - ✅<br><sub>The score is 0.00 because the retrieval contexts only contain nodes that are irrelevant to the input, and thus do not contribute towards increasing the contextual precision score.</sub> |
| **Context Recall** | 0.00 - ✅<br><sub>The score of 1 indicates that this node in the retrieval context is supportive, as it contains a reason why the original expected output can be attributed to the given node.</sub> | 0.00 - ✅<br><sub>The score of 1 indicates that this node in the retrieval context is supportive, as it contains a reason why the original expected output can be attributed to the given node.</sub> |

#### Responses
<details><summary><b>View Standard Response</b></summary>

```text
**Clinical Summary:**
The patient, Sumiko254 Larue605 Medhurst46, has an active diagnosis of Type 2 Diabetes and HIV. The retrieved FHIR evidence indicates that the patient's Prediabetes condition is active, with an onset date of 1972-04-29T22:58:16-05:00. Additionally, the patient's Condition: Malignant neoplasm of breast (disorder) and Non-small cell carcinoma of lung, TNM stage 1 (disorder) are also active, with onset dates of 1989-04-10T01:18:07-04:00 and 1984-11-01T19:35:22-05:00, respectively. There is no mention of an active HIV diagnosis in the retrieved evidence.

**Record Evidence:**

* Condition: Prediabetes (disorder). Status: active. Onset: 1972-04-29T22:58:16-05:00.
* Condition: Malignant neoplasm of breast (disorder). Status: active. Onset: 1989-04-10T01:18:07-04:00.
* Condition: Non-small cell carcinoma of lung, TNM stage 1 (disorder). Status: active. Onset: 1984-11-01T19:35:22-05:00.

**Clinical Status:**
The conditions of Type 2 Diabetes and HIV are UNKNOWN, as there is no mention of an active HIV diagnosis in the retrieved evidence. However, the patient's Prediabetes condition is ACTIVE, indicating a current diagnosis of diabetes.

**Confidence Level:** Medium (Med)

Note: The confidence level is medium because while we can confirm that the patient has an active diagnosis of Type 2 Diabetes, there is no clear indication of an active HIV diagnosis in the retrieved evidence.
```
</details>

<details><summary><b>View Verified Response</b></summary>

```text
**Clinical Consultation Report**

**Patient-Specific Synthesis:**
Sumiko254 Larue605 Medhurst46 is a 74-year-old patient with multiple active diagnoses, including Malignant neoplasm of breast (active since 1989), Non-small cell carcinoma of lung (active since 1984), Anemia (active since 1972), Sepsis (active since 1976), Ischemic heart disease (active since 1977), and Prediabetes (active since 1972). The patient has a history of coronary artery bypass grafting (active since 1977) and is currently under treatment for these conditions. Additionally, there are reports of violence in the environment, which appears to be unrelated to the patient's current medical conditions.

**Literature-Based Context:**
The PubMed articles provided offer insights into various aspects of the patient's conditions. The article "Central adiposity outperforms disordered eating behavior in predicting type 2 diabetes risk in young adults" (ID: 42052024) highlights the importance of central adiposity in predicting type 2 diabetes risk, which may be relevant to Sumiko's Prediabetes diagnosis. However, without explicit evidence of Type 2 Diabetes, it is unclear whether this patient meets the criteria for this condition.

The article "Prevalence and risk factors of sarcopenia in Asian adults with type 2 diabetes: A systematic review and meta-analysis" (ID: 42052637) discusses the prevalence and risk factors of sarcopenia in patients with Type 2 Diabetes. While not directly applicable to Sumiko's case, it emphasizes the importance of monitoring muscle mass and strength in patients with chronic diseases.

The article "The prevalence and predictor factors of urinary tract infection in type 2 diabetes mellitus patients receiving SGLT2 inhibitors in Qatar: A retrospective cohort study" (ID: 42052097) explores the risk of urinary tract infections in patients taking SGLT2 inhibitors for Type 2 Diabetes. This information is not directly relevant to Sumiko's current treatment regimen.

**Recommendation Logic:**
Based on standard medical practice, it is essential to monitor and manage Sumiko's multiple active conditions simultaneously. Given her Prediabetes diagnosis, it would be prudent to implement lifestyle modifications and consider pharmacological interventions to prevent progression to Type 2 Diabetes. Regular monitoring of her muscle mass and strength (sarcopenia) could also be beneficial, especially considering her history of Anemia and Sepsis.

**PUBMED Verification:**
The PubMed articles provided offer valuable insights into various aspects of Sumiko's conditions, but some information is not directly applicable to her case. The lack of explicit evidence for Type 2 Diabetes and HIV in the provided FHIR records warrants further investigation or clarification from other sources.

**Confidence Level:** Medium

The confidence level remains medium due to the limited information available on Sumiko's specific health data and the need for further investigation into her Prediabetes diagnosis and potential risk factors for Type 2 Diabetes.
```
**PubMed Verification:**
```text
**
The PubMed articles provided offer valuable insights into various aspects of Sumiko's conditions, but some information is not directly applicable to her case. The lack of explicit evidence for Type 2 Diabetes and HIV in the provided FHIR records warrants further investigation or clarification from other sources.

**Confidence Level:** Medium

The confidence level remains medium due to the limited information available on Sumiko's specific health data and the need for further investigation into her Prediabetes diagnosis and potential risk factors for Type 2 Diabetes.
```
</details>

---
